CPBIO Holding Company Limited
Other OTCTotal Valuation
CPBIO Holding Company Limited carries a market capitalization of 829.16M, placing it among publicly traded companies globally. Its enterprise value stands at 61.33M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 829.16M |
| Enterprise Value | 61.33M |
Share Statistics
CPBIO Holding Company Limited currently has 240.72M shares outstanding.
| Shares Outstanding | 240.72M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
On an enterprise value basis, CPBIO Holding Company Limited trades at an EV/EBITDA multiple of 199.08 and an EV/FCF ratio of 109.45. The EV/Sales ratio of 0.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 199.08 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.67 |
| EV / EBITDA | 199.08 |
| EV / EBIT | 199.08 |
| EV / FCF | 109.45 |
Financial Position
CPBIO Holding Company Limited maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.24, indicating elevated leverage, while an interest coverage ratio of -2.37 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.47 |
| Quick Ratio | 0.38 |
| Debt / Equity | 31.24 |
| Debt / EBITDA | -26.48 |
| Interest Coverage | -2.37 |
Financial Efficiency
| Return on Equity (ROE) | 0.67 |
| Return on Assets (ROA) | 0.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -0.69 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 13.01 |
Taxes
Over the trailing twelve months, CPBIO Holding Company Limited has paid 633,000.00 in income taxes, reflecting an effective tax rate of 265.97.
| Income Tax | 633,000.00 |
| Effective Tax Rate | 265.97 |
Stock Price Statistics
CPBIO Holding Company Limited's stock has gained approximately 281.32143% over the past 52 weeks. The 50-day moving average sits at 0.55, while the 200-day moving average is 0.35.
| Beta (5Y) | N/A |
| 52-Week Price Change | 281.32143% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.35 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, CPBIO Holding Company Limited generated 91.17M in revenue and converted that into 526,000.00 in net income, yielding earnings per share of 0.00. EBITDA reached -2.95M, while operating income came in at -2.95M.
| Revenue | 91.17M |
| Gross Profit | 15.36M |
| Operating Income | -2.95M |
| Pretax Income | 238,000.00 |
| Net Income | 526,000.00 |
| EBITDA | -2.95M |
| EBIT | -2.95M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
CPBIO Holding Company Limited holds 41.96M in cash and equivalents against 78.18M in total debt, resulting in a net debt position of 36.22M. Total book value stands at 225.17M, with working capital of 51.11M providing operational flexibility.
| Cash & Cash Equivalents | 41.96M |
| Total Debt | 78.18M |
| Net Debt | 36.22M |
| Equity (Book Value) | 225.17M |
| Book Value Per Share | 0.94 |
| Working Capital | 51.11M |
Margins
CPBIO Holding Company Limited operates with a gross margin of 16.84, reflecting its pricing power and cost economics. The operating margin of -3.24 and net profit margin of 0.58 provide insight into operational efficiency.
| Gross Margin | 16.84 |
| Operating Margin | -3.24 |
| Pretax Margin | 0.26 |
| Profit Margin | 0.58 |
| EBITDA Margin | -3.24 |
Scores
CPBIO Holding Company Limited posts an Altman Z-Score of 0.38, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.38 |